HUTCHMED (China) Limited (HCM) stock analysis

In our weekly check, HUTCHMED (China) Limited is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 4, red flags: 6.

Sector: Healthcare · Drug Manufacturers—Specialty & Generic

Strengths

Warning signs

Similar companies

BHC · PRGO · ALVO · ANIP · ETON · PCRX

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis